96873 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
Multivalent Chlorotoxin Chimeric Antigen Receptors
#2RECOMBINANT EXPRESSION VECTOR FOR SECRETION OF CHLOROTOXIN, AND ATTENUATED SALMONELLA STRAIN TRANSFORMED BY MEANS OF SAME
#3CAR-EXPRESSING PLURIPOTENT STEM CELL-DERIVED NEUTROPHILS LOADED WITH DRUG NANOPARTICLES AND USES THEREOF
#4RECOMBINANT MICROORGANISM-BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE
#5CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF
#6HV1 MODULATORS AND USES
#7IPSC-Based Gamma-Delta T-Cells, Compositions and Methods of Use Thereof
#8Bispecific Binding Molecule
#9PHOTOACTIVATABLE ION CHANNEL MODULATOR
#10TUMOR HOMING AND CELL PENETRATING PEPTIDE-IMMUNO-ONCOLOGY AGENT COMPLEXES AND METHODS OF USE THEREOF
#11PD-L1 BINDING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#12ANTIMICROBIAL PEPTIDES WITH ALPHA-CORE HELICES
#13HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE
#14KV1.3 Blockers
#15CHLOROTOXIN DERIVATIVES AND USE THEREOF
#16KV1.3 BLOCKERS
#17HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE
#18TRUNCATED CHLOROTOXIN FUSION PROTEINS AND METHODS OF USE THEREOF
#19DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISING IL-13 AND CHLOROTOXIN FOR CANCER TREATMENT
#20COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#21HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS
#22METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES
#23Antimicrobial peptides with alpha-core helices
#24Tissue-homing peptide conjugates and methods of use thereof
#25METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS
#26CHIMERIC CHLOROTOXIN RECEPTORS
#27HV1 modulators and uses
#28Kv1.3 blockers
#29CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN
#30FUSION PROTEIN WITH A TOXIN AND SCAFFOLD PROTEIN
#31KV1.3 blockers
#32Compositions and related methods for controlling vector-borne diseases
#33CARTILAGE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF
#34Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof
#35Coiled coil immunoglobulin fusion proteins and compositions thereof
#36Humanized antibodies with ultralong complementary determining regions
#37KV1.3-BLOCKING VENOM PEPTIDE VARIANTS AND RELATED USES
#38CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF
#39ANTIMICROBIAL PEPTIDES WITH ALPHA-CORE HELICES
#40Cartilage-homing peptide conjugates and methods of use thereof
#41COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES
#42Chimeric chlorotoxin receptors
#43Methods of reducing neuronal injury or toxicity in epilepsy, Alzheimer's disease or Parkinson's disease using a scorpion venom heat-resistant synthetic peptide (SVHRSP)
#44Chimeric antigen receptors containing a chlorotoxin domain
#45HV1 modulators and uses
#46Methods of treating breast cancer
#47Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient
#48METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES
#49Use of La1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals
#50LIPOCALIN FUSION PARTNERS
#51Kv1.3 Antagonists and Methods of Use
#52Chlorotoxin variants, conjugates, and methods for their use
#53Compositions and methods for peptide expression and purification using a type III secretion system
#54Chlorotoxin polypeptides and conjugates and uses thereof
#55Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers
#56METHOD FOR PURIFYING AND RENATURATING INCLUSION BODIES OF SCORPION TOXIN PROTEIN AND THEIR USE
#57Scorpion toxin analogue and method for treating autoimmune diseases
#58Humanized antibodies with ultralong complementary determining regions
#59Coiled coil immunoglobulin fusion proteins and compositions thereof
#60Chlorotoxin polypeptides and conjugates and uses thereof
#61CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF
#62Lipocalin fusion partners
#63METHODS FOR SCREENING
#64Compositions and methods for peptide expression and purification using a type III secretion system
#65Modified peptide toxins
#66Chlorotoxin polypeptides and conjugates and uses thereof
#67Kv1.3 antagonists and methods of use
#68FLUORESCENT CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER
#69Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
#70Peptide toxin formulation
#71Analgesic active peptide VGG, preparation and use thereof
#72COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS
#73COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS
#74Chlorotoxin variants, conjugates, and methods for their use
#75Chlorotoxin polypeptides and conjugates and uses thereof
#76Peptide toxin formulation
#77p53 activator peptides
#78Polypeptides having Antimicrobial Activity and Polynucleotides Encoding Same
#79Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
#80Identification of toxin ligands
#81Peptide toxin formulation
#82Methods of using OSK1 peptide analogs
#83DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression
#84DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression
#85Methods of using conjugated toxin peptide therapeutic agents
#86Conjugated toxin peptide therapeutic agents
#87OSK1 peptide analogs and pharmaceutical compositions
#88Directed evolution of novel binding proteins
#89ABC transporter ligand GATX1
#90Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
#91Compositions and methods for producing bioactive fusion proteins
#92Maurotoxin, PI1 and HSTX1 derivatives
#93ORALLY ACTIVE ANDROCTONUS AMOREUXI PESTICIDAL BIOPEPTIDES
#94Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer
#95Compositions and Methods for Assaying hERG Channel Binding
#96SYNTHESIS, MODIFICATION AND REDUCTION OF PRIMARY STRUCTURE OF HYPOTENSIVE PEPTIDES PRESENT IN SCORPION VENOM FOR OPTIMIZING THEIR USE AS A HYPOTENSIVE MEDICAMENT
#97DIRECTED EVOLUTION OF NOVEL BINDING PROTEINS
#98Chlorotoxin-labeled nanoparticle compositions and methods for targeting primary brain tumors
#99Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin
#100Peptide for assaying hERG channel binding
#101Polypeptides having antimicrobial activity and polynucleotides encoding same
#102Method of using a peptide having analgesic and antitumor activity from scorpion
#103Cholesterol biosynthesis pathway modulators and uses thereof
#104Expression of defensins in filamentous fungi
#105Cardiotonic polypeptides
#106Treatment of cell proliferative disorders with chlorotoxin
#107Scorpion peptide as hypotensive agent
#108Novel method of diagnosing and treating gliomas
#109Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus
#110Scorpion toxins
#111Tissue-homing peptide conjugates and methods of use thereof
#112Refolded chlorotoxin, chlorotoxin variant, refolded chlorotoxin variant, and preparation technology thereof